|
MORE DETAILS
|
USEFUL READING
|
Plug and play?
Published by PMLive.com, 27 January 2010
There has been a trend towards mandatory CME across Europe in recognition of the vital role it plays in updating physicians on new developments in their field, as well as in maintaining competence and improving public confidence in the healthcare profession. However, there is considerable disparity in the way that CME programmes are organised and run within Europe.
[Read on to find out more]
|
|
|
Good publication practice for communicating company sponsored medical research: the GPP2 guidelines
Published by BMJ.com, 29 November 2009
Written by a team led by Chris Graf, and published in the BMJ, in response to changes in the environment in which authors, presenters, and other contributors work together to communicate medical research the International Society for Medical Publication Professionals (ISMPP) has updated the good publication practice guidelines.
[Read on to find out more]
|
|
|
Inform or influence
Published by PMLive.com, 7 October 2009
The European continuing medical education (CME) environment is evolving significantly; pharma used to look at it with foot-shuffling inquisitiveness, but is now more willing to question its potential. Pharmaceutical companies are considering whether steering clear of it puts them at a competitive disadvantage or if providing a grant for CME would benefit them – especially in today's tightening regulatory environment.
[Read on to find out more]
|
|
|
The gold standard
Published by PMLive.com, 1 October 2009
The Certified Medical Publication Professional (CMPP) credential reflects the evolution of an industry that is striving to raise the bar of professionalism and competency in its medical publication planning activities. Article written by Alfred Weigel is director, medical publications, at Boehringer-Ingelheim Pharmaceuticals and ISMPP President, 2009-2010.
[Read on to find out more]
|
|
|
Highlights from the Fifth Annual Meeting of the International Society for Medical Publication Professionals
Published by ISMPP, 18 September 2009
The 5th Annual Meeting of the International Society of Medical Publication Professionals (ISMPP), held April 20 to April 22, at the Sheraton Philadelphia City Center Hotel in Philadelphia, Pennsylvania, saw publication professionals from around the globe gather to further define the role of the medical publication professional in light of the changing medical publications industry. In line with this year’s theme, “Defining Professionalism in Medical Publications: Transparency, Objectivity, and Ethics,” the meeting was characterized by heightened awareness of the importance of transparency in industry-sponsored research and publications, a technology-driven trend toward open-access publishing, and the requirement for online clinical trial data posting as mandated by the Food and Drug Administration Amendment Act of 2007 (FDAAA).
[Read on to find out more]
|
|
|
Winning webinars
Published by PMLive.com, 18 August 2009
Other industry sectors realise that 'webinars' can be a company's most cost effective customer interaction tool. Pharma needs to catch up and start to look at 'Return on Webinar' (RoW) as a new measure, argues Alex Monaghan
[Read on to find out more]
|
|
|
Can the Relationship between Doctors and Drug Companies Ever Be a Healthy One?
Published by PLOS Medicine, 21 July 2009
In this PLOS Medicine debate, Emma D'Arcy, co-founder of a social networking site that facilitates interactions between doctors and drug companies, argues that it would be valuable to the public if we could establish “authentic alliances” between these professionals. But journalist Ray Moynihan argues that such alliances are prone to the corrupting influence of pharmaceutical industry money, and that disentanglement is a healthier alternative.
[Read on to find out more]
|
|
|
Top ten tips for conference posters
Published by The Publication Plan, 8 July 2009
Posters prepared for medical conferences are an important part of any publications plan. Jane Fraser provides some useful tips.
[Read on to find out more]
|
|
|
Cutting-edge delivery
Published by PMLive, 15 June 2009
A recent report from the Healthcare Communications Association (HCA) showed that 58 per cent of surveyed agency members are seeing an increase in medical education (med ed), and about a third is seeing an increase in PR, with a corresponding third seeing a decrease.
[Read on to find out more]
|
|
|
The Changing Shape of Healthcare Communications - Summary Report of Annual Benchmarking Survey 2008
Published by The Healthcare Communication Association (HCA), January 2009
The Healthcare Communications Association (HCA) conducts an annual benchmarking survey, exploring trends in the provision of communication services to the healthcare industry. This report provides a short summary of the findings that have been disseminated in detail to the survey participants.
[Read on to find out more]
Download the Appendix to learn More about the HCA and a special supplement to learn more about one of the core topics, Consultancy selection and the procurement process.
|
|
|
What to look for in a publication planning agency
Published by The Publication Plan, 5 January 2009
Not all agencies are created equal, and the importance of establishing the ‘right fit’ between your organisation’s business need and the capability and capacity of your partner agency is one of the most important strategic decisions your project team will make.
[Read on to find out more]
|
|
|
Highlights from the Fourth Annual Meeting of the International Society for Medical Publication Professionals
Published by ISMPP, November 2008
The fourth annual meeting of the International Society for Medical Publication Professionals (ISMPP) was held in Philadelphia, Pennsylvania, from April 28th to April 30th, 2008. More than 430 publications professionals from the United States and Europe attended. This year’s program, Mapping Success: New Rules of the Road for Medical Publications, included valuable information about the Food and Drug Administration Amendment Act (FDAAA) of 2007 and its implications for publications planning and execution, technical issues and advances that affect the publication process, and global publications considerations and guidance.
[Read on to find out more]
|
|
|
Impact of legislation and reporting standards on publication planning
Published by The Publication Plan, 11 November 2008
The publication planning landscape has changed dramatically over the past 10 years. We have moved from an arena largely free of restriction and regulation to one that has come under intense and sustained scrutiny from several sources – legislators, journal editors, medical societies, commentators and even mainstream newspapers. Today, many Pharma companies have publication policies and procedures in place to routinely register clinical trial protocols, and some have ensured that summaries of past trial results (published or not) are publicly available on their own registries.
[Read on to find out more]
|
|
|
Publication Planning 2.0
Published by The Publication Plan, 11 September 2008
Publication should only be the first stage in ensuring maximum impact for your research. Matt McKay suggests that implementation of communication strategies and Web 2.0 technologies can bring significant additional benefits post-publication.
[Read on to find out more]
|
|
|
Mandatory disclosure of trial results for drugs and devices
Published by BMJ, 26 January 2008
The FDA Amendments Act, passed quietly last year, rules that any ongoing clinical trial involving a drug, biological product, or device regulated by the US Food and Drug Administration (FDA) must be registered at clinicaltrials.gov and that, from 27 September 2008, triallists must start to post in that same registry the results of those trials.3 This applies to all clinical trials of drugs and devices except phase I drug trials (preliminary safety studies for new products) and small feasibility studies of a device. Furthermore, it covers all trials - whether or not they are conducted and sponsored by industry and wherever they are conducted - if the products concerned need approval by the FDA.
So will a journal still want to publish a paper if its results have been posted on clinicaltrials.gov; if they have been debated widely in the mass media along with quotes from respected clinical experts, and - as is often the case - if they have led to a widely publicised rise or fall in the share price of the company that sponsored the trial? And, in the long run, will the role of peer reviewers and medical journals as the gatekeepers of new medical evidence become redundant?
[Read on to find out more]
|
|
|
Highlights from the Third Annual Meeting of the International Society for Medical Publication Professionals
Published by ISMPP, August 2007
The third annual meeting of the International Society for Medical Publication Professionals (ISMPP) was held in Philadelphia, PA, from April 23rd to 25th and was attended by approximately 400 publication professionals from the United States and Europe. The number of meeting participants grew by more than 40% over last year’s meeting! There were 29 sponsors and exhibitors; this too was a significant increase over 2006.
This year’s program, Ensuring Integrity in Medical Publications: Conflicts, Credibility, & Collaboration, focused on issues surrounding the management of conflict of interest (COI), the promotion of successful collaboration among all medical publication stakeholders, the need for increased transparency, and increased requirements for adherence to legal and regulatory guidelines and best practices. The 3-day meeting was comprised of 4 full-day workshops followed by 2 days of plenary presentations and discussions, a breakfast roundtable on the draft Ethics Statement of ISMPP, and 14 poster presentations on medical publication-related research and related topics. A new feature added to the 2007 meeting was podium presentations by a select group of ISMPP members, who were chosen based on the submission of abstracts on key topics of interest to the membership. The abstracts were selected by an independent abstract review committee. In total, there were 8 such oral presentations, presented in parallel tracks on the second day of the meeting.
[Read on to find out more]
|
|
|
Do Medical Journals Provide Clear and Consistent Guidelines on Authorship?
Published by Medscape, July 2007
Determining the authorship of scientific papers can be difficult and authorship disputes are common. Less experienced authors may benefit from clear advice about authorship from journals while both authors and readers would benefit from consistent policies between journals. However, previous surveys of authors have suggested that there are no universally known or accepted criteria for determining authorship. Liz Wager examined the instructions to contributors from 234 biomedical journals (randomly selected from the membership list of the World Association of Medical Editors and from Medline). Of the 234 instructions examined, 100 (41%) gave no guidance about authorship, 68 (29%) were based on the International Committee of Medical Journal Editors' (ICMJE) criteria, 33 (14%) proposed other criteria, and 33 (14%) said nothing except that all authors should have approved the manuscript. Of those instructions that were based on the ICMJE criteria, 18/51 (35%) cited an outdated version. Only 21 of the journals (9%) required individuals' contributions to be described. Liz concluded that journals do not provide consistent guidance about authorship and many editors are therefore missing an important opportunity to educate potential contributors and to improve the accuracy, fairness, and transparency of author listing.
[Read on to find out more] (registration required).
|
|
|
International Society for Medical Publication Professionals (ISMPP) position statement: the role of the professional medical writer
Published by Current Medical Research and Opinion, June 2007
The International Society for Medical Publication Professionals (ISMPP) is an independent, nonprofit professional association with members from the pharmaceutical, medical device, and biotechnology industries; publication planning and medical communications companies; academia; and medical journal staffs, including editors and publishers. ISMPP’s mission is to support the educational needs of medical publication professionals by providing a forum to facilitate awareness and development of best practices in publication planning and implementation, and fostering consensus policies related to medical publishing. This position statement reflects our concern about the current climate of mistrust regarding the use of professional medical writers in the preparation of manuscripts. We acknowledge the skills and training of medical writing professionals and support their role in working with research teams to develop clear and concise manuscripts in a timely fashion. Further, we support complete and transparent disclosure of the role of the medical writer and the source of funding for the writing initiative in order to build awareness of, and trust in, the appropriate use of medical writing professionals. ISMPP endorses use of the contributorship model, which offers detailed information on the roles of all who participated in planning, conducting, developing, and publishing medical research. Further, we propose that this model be integrated into the standard operating procedures of the diverse organizations that comprise our membership because the responsibility for authorship disclosure is shared by sponsors, authors, study investigators, and medical writers. Finally, we commend the many organizations that have worked to increase recognition and understanding of the legitimate role of the medical writer, and are eager to work in concert with them to ensure the rigorous maintenance of all ethical standards for reporting the results of medical research.
[Read on to find out more]
|
|
WHAT ELSE?
|
|
|
|
|
|
|
|
|
|
|
|
- Advert - - - - - - -
FREE REPORTS
The following KeywordPharma reports are all highly relevant to medical communications and are freely available to download thanks to support from sponsors
Report of 2nd Annual Meeting of the European CME Forum - written by Eugene Pozniak and David Williams, published February 2010
Report of The International Publication Planning Association's 7th Annual Meeting - written by Liz Wager, published September 2009
Aligning Aspirations and Realising Ambitions: the challenges of the new era of engagement between experts and the pharmaceutical industry - written by Emma D'Arcy, published May 2009
European CME Forum: First Annual Meeting - written by Eugene Pozniak, published February 2009
FDAAA Legislation: Global Implications for Clinical Trial Reporting and Publication Planning - written by Liz Wager, published November 2008
Tightening Regulations and Raising Standards in UK Marketing Communications: the new ABPI Code of Practice (2008) explained - written by Steven Gray, published June 2008
Increasing Transparency in Pharmaceutical Marketing Communications: the new code from the European Federation of Pharmaceutical Industries and Associations (EFPIA) - written by Joan Barnard, Rene Lai and Andrew Robson, published February 2008
The Changing Face of CME in Europe: Where Are We Now? - written by Eugene Pozniak, published November 2007
Strategies and Solutions for Publication Planning and Execution Excellence - written by Liz Wager, published September 2007
Medical Writers and Peer-Reviewed Journals: Understanding the Rules and Responsibilities - written by Liz Wager, published June 2007
Download these KeywordPharma reports here
|
|
|
